Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure.

Participation in a comprehensive cardiac rehabilitation (CR) program has been shown to reduce mortality and improve exercise capacity and symptoms in patients with chronic heart failure (CHF). Reduced exercise capacity leads to a concomitant reduction of skeletal muscle mass and accumulation of body fat. However, it is currently unknown whether CR reduces visceral adipose tissue (VAT) and/or subcutaneous abdominal adipose tissue (SAT) in patients with CHF. In addition, the body composition associated with improved exercise capacity after CR in patients with CHF has not been previously studied. Nineteen CHF patients who were categorized as NYHA functional class II or III and had received optimal medical treatment including a CR program for 5 months were enrolled in this study. The CR program significantly increased peak VO2 and reduced B-type natriuretic peptide. In addition, fat and body composition analysis showed reductions in the visceral fat tissue (VAT) area, subcutaneous abdominal adipose tissue (SAT) area, body weight, and total fat weight after CR. There were no changes in total water weight and total muscle weight. Single regression analysis revealed that the amelioration of reduced exercise capacity seen after CR is associated with reduced VAT area but not with SAT area or body weight. In conclusion, CR reduces VAT and improves exercise capacity in patients with CHF. This suggests that reducing VAT is important for CR to be most effective in the treatment of CHF.

[1]  Sung Hee Choi,et al.  Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. , 2016, Journal of diabetes and its complications.

[2]  I. Janszky,et al.  Body Mass Index, Abdominal Fatness, and Heart Failure Incidence and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies. , 2016, Circulation.

[3]  T. Pithon-Curi,et al.  Benefits of Regular Exercise on Inflammatory and Cardiovascular Risk Markers in Normal Weight, Overweight and Obese Adults , 2015, PloS one.

[4]  R. Bonow,et al.  The role of metabolic syndrome in heart failure. , 2015, European heart journal.

[5]  A. Kriska,et al.  Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD , 2015, Diabetes Care.

[6]  R. Touyz,et al.  Exercise training protects against atherosclerotic risk factors through vascular NADPH oxidase, extracellular signal‐regulated kinase 1/2 and stress‐activated protein kinase/c‐Jun N‐terminal kinase downregulation in obese rats , 2015, Clinical and experimental pharmacology & physiology.

[7]  M. Akaike,et al.  Impact of supervised cardiac rehabilitation on urinary albumin excretion in patients with cardiovascular disease. , 2015, International heart journal.

[8]  K. Aihara,et al.  Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy men , 2014, Diabetology & Metabolic Syndrome.

[9]  J. Després,et al.  Visceral and Not Subcutaneous Abdominal Adiposity Reduction Drives the Benefits of a 1‐Year Lifestyle Modification Program , 2012, Obesity.

[10]  D. Jędrzejuk,et al.  Left Ventricular Function Impairment in Patients With Normal-Weight Obesity: Contribution of Abdominal Fat Deposition, Profibrotic State, Reduced Insulin Sensitivity, and Proinflammatory Activation , 2012, Circulation. Cardiovascular imaging.

[11]  J.,et al.  The New England Journal of Medicine , 2012 .

[12]  P. Scuffham,et al.  Exercise training in recently hospitalized heart failure patients enrolled in a disease management programme: design of the EJECTION‐HF randomized controlled trial , 2011, European journal of heart failure.

[13]  A. Coats.  Clinical utility of exercise training in chronic systolic heart failure , 2011, Nature Reviews Cardiology.

[14]  C. Dieli-Conwright,et al.  Validity and reliability of body composition analysers in children and adults , 2008, British Journal of Nutrition.

[15]  Udo Hoffmann,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[16]  J. Murabito,et al.  Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress: The Framingham Heart Study , 2007, Circulation.

[17]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[18]  L. Ploutz-Snyder,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(3):1511–1518 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1782 Exercise Is Required for Visceral Fat Loss in Postmenopausal Women with Type 2 D , 2022 .

[19]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[20]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[21]  E. Kraegen,et al.  Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. , 2003, Diabetes care.

[22]  D. Levy,et al.  Obesity and the risk of heart failure. , 2003, The New England journal of medicine.

[23]  S. Ellahham,et al.  Chronic heart failure and exercise. , 2000, American heart journal.

[24]  E. Poehlman,et al.  Obesity, body fat distribution, and coronary artery disease. , 2000, Journal of cardiopulmonary rehabilitation.

[25]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[26]  G. Pergola,et al.  Obesity and heart failure. , 2013, Nutrition reviews.